Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARX | AMGN | GILD | CELG | VRTX |
| Company | Ra Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 47.99 | 264.63 | 66.25 | 108.01 | 394.72 |
| High | 48.01 | 267.69 | 66.72 | 108.59 | 396.98 |
| Low | 47.98 | 260.68 | 66.16 | 107.27 | 393.00 |
| Last | 48.00 | 267.27 | 66.43 | 108.24 | 393.21 |
| Change | -0.02 | +4.52 | +0.27 | +0.11 | -0.27 |
| % Change | -0.03% | +1.72% | +0.41% | +0.10% | -0.07% |
| Volume | 3,864,600 | 1,212,922 | 3,829,434 | 191,230,496 | 589,916 |
| 20-Day Average Volume | 1,869,975 | 2,136,065 | 6,105,215 | 16,188,930 | 893,146 |
| Previous Close | 48.01 | 262.75 | 66.16 | 108.13 | 393.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 46.03 | 272.45 | 69.87 | 108.17 | 405.53 |
| 20-Day Raw Stochastic | 99.68% | 21.48% | 4.64% | 63.25% | 11.47% |
| 20-Day Relative Strength | 56.47% | 41.48% | 28.55% | 64.69% | 37.99% |
| Weighted Alpha | +21.70 | +6.42 | -25.10 | +46.30 | +16.04 |
| Today's Opinion | 56% Buy | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 56% Buy | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 80% Buy | 8% Sell | 72% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 03/25/20 | -0.23% since 04/12/24 | -2.64% since 04/12/24 | -1.97% since 11/13/19 | -0.52% since 04/12/24 |
| Low | 46.34 on 03/26/20 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
| High | 48.02 on 03/31/20 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | +2.64% since 02/28/20 | -1.86% since 03/19/24 | -9.73% since 03/19/24 | +5.14% since 10/18/19 | -4.99% since 03/19/24 |
| Low | 40.30 on 03/18/20 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 48.02 on 03/31/20 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +2.27% since 12/31/19 | -13.37% since 01/19/24 | -24.08% since 01/19/24 | +13.63% since 08/20/19 | -9.31% since 01/19/24 |
| Low | 40.30 on 03/18/20 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 48.02 on 03/31/20 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +112.27% since 10/01/19 | -4.96% since 10/19/23 | -15.52% since 10/19/23 | +14.14% since 05/20/19 | +8.14% since 10/19/23 |
| Low | 22.25 on 10/08/19 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 48.02 on 03/31/20 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,271,555 | 140,812,720 | 82,374,304 | 77,035,920 | 101,698,464 |
| Shares Outstanding, K | 47,329 | 535,919 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 3,000,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -102,690,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 3,000,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -24,980,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.04 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/14/20 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 29.25 |